These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

162 related items for PubMed ID: 1927767

  • 1. [Combination chemotherapy of methotrexate, etoposide, adriamycin and cisplatin (M-EAP) for advanced urothelial cancer].
    Hashimura T, Okumura K, Akao T, Nakagawa T.
    Hinyokika Kiyo; 1991 Jul; 37(7):685-8. PubMed ID: 1927767
    [Abstract] [Full Text] [Related]

  • 2. [MEP (methotrexate, etoposide and cisplatin) and M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced uroepithelial cancer--a preliminary report of MEP as second line chemotherapy for recurrence after M-VAC].
    Seguchi T, Nakano E, Miki T, Kondoh M, Nishimura K, Nakamura N, Okuyama A.
    Gan To Kagaku Ryoho; 1994 Jan; 21(1):59-65. PubMed ID: 8291917
    [Abstract] [Full Text] [Related]

  • 3. Adjuvant chemotherapy for invasive urothelial cancer: experience with a methotrexate, vincristine, cisplatin, cyclophosphamide, adriamycin and bleomycin (MVP-CAB) regimen: a preliminary report.
    Gohji K, Higuchi A, Maruyama S, Minayoshi K, Fujii A, Itoh N, Hasunuma Y, Tanaka H, Izumi T.
    Jpn J Clin Oncol; 1993 Oct; 23(5):291-8. PubMed ID: 7693990
    [Abstract] [Full Text] [Related]

  • 4. [Clinical and pathological evaluations of methotrexate, vinblastine, adriamycin and cisplatin (M-VAC) chemotherapy for advanced urothelial cancers].
    Takenaka A, Gotoh A, Hara I, Gohji K, Ogawa T, Arakawa S, Matsumoto O, Kamidono S, Hamami G, Itani A.
    Gan To Kagaku Ryoho; 1990 Sep; 17(9):1909-15. PubMed ID: 2393308
    [Abstract] [Full Text] [Related]

  • 5. [Experience with combination chemotherapy consisting of methotrexate, vinblastine, adriamycin and cisplatin (M-VAC) in advanced urothelial cancer].
    Nishio Y, Shirahase T, Shichiri Y, Habuchi T, Matsuda T, Nishimura K, Hida S, Okada Y, Yoshida O.
    Hinyokika Kiyo; 1988 Aug; 34(8):1371-5. PubMed ID: 3195405
    [Abstract] [Full Text] [Related]

  • 6. [M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) chemotherapy in advanced renal pelvic and ureteral carcinoma].
    Igawa M, Ueki T, Ueda M, Okada K, Usui T, Ohnishi Y, Kume T, Masu C, Ishino T, Nakatsu H.
    Gan To Kagaku Ryoho; 1989 Aug; 16(8 Pt 1):2577-82. PubMed ID: 2673046
    [Abstract] [Full Text] [Related]

  • 7. [Sequential combination chemotherapy consisting of vincristine, peplomycin, methotrexate, cis-diamminedichloroplatinum (II), cytosine arabinoside and 5-fluorouracil, for advanced urothelial cancer].
    Yamauchi T, Hida S, Ooishi K, Okada K, Yoshida O.
    Hinyokika Kiyo; 1985 Jul; 31(7):1093-104. PubMed ID: 2414981
    [Abstract] [Full Text] [Related]

  • 8. [Results of combination chemotherapy in advanced urothelial cancer].
    Komatsubara S, Watanabe M, Kitamura Y, Sakata Y.
    Hinyokika Kiyo; 1988 Oct; 34(10):1697-702. PubMed ID: 3245518
    [Abstract] [Full Text] [Related]

  • 9. Methotrexate, vinblastine, adriamycin and cisplatin (MVAC) chemotherapy for the treatment of advanced bladder carcinoma.
    Balbay MD, Ozen H, Uluçay S, Sahin A, Ergen A, Koçal C, Remzi D.
    Int Urol Nephrol; 1993 Oct; 25(4):351-7. PubMed ID: 8276565
    [Abstract] [Full Text] [Related]

  • 10. [Sequential combination chemotherapy consisting of vincristine, peplomycin, methotrexate, cis-diamminedichloroplatinum (II) and adriamycin in urothelial cancer].
    Konami T, Wakabayashi Y, Kim T, Ishida A, Arai Y, Konishi T, Pak K, Takeuchi H, Tomoyoshi T, Watanabe J.
    Hinyokika Kiyo; 1989 Feb; 35(2):231-7. PubMed ID: 2472048
    [Abstract] [Full Text] [Related]

  • 11. [Early clinical result of modified M-VAC (methotrexate, vinblastine, doxorubicin, and cisplatin) for advanced transitional cell carcinoma of renal pelvis and ureter].
    Shishido S, Hayakawa M, Higa I, Koyama Y, Hatano T, Osawa A.
    Hinyokika Kiyo; 1990 Apr; 36(4):401-5. PubMed ID: 2378303
    [Abstract] [Full Text] [Related]

  • 12. [Combination chemotherapy with M-VAC protocol in metastatic urothelial cancer].
    Sella A, Flex D, Gafni D, Rabinovitz O, Sulkes A, Baniel J.
    Harefuah; 1999 Feb 15; 136(4):268-71, 340, 339. PubMed ID: 10914214
    [Abstract] [Full Text] [Related]

  • 13. [M-VAC chemotherapy for patients with lymph node metastases and/or locally advanced bladder carcinoma].
    Igawa M, Ueki T, Ueda M, Okada K, Usui T, Ohnishi Y, Nakatsu H, Kume T, Kodama M, Masu C.
    Hinyokika Kiyo; 1989 Aug 15; 35(8):1323-7. PubMed ID: 2683648
    [Abstract] [Full Text] [Related]

  • 14. [Clinical studies of chemotherapy for patients with a solitary kidney after nephroureterectomy for advanced upper urothelial transitional cell carcinoma].
    Tsujimura A, Takayama H, Tsukikawa M, Imazu T, Sugao H, Takaha M.
    Hinyokika Kiyo; 1995 Mar 15; 41(3):183-9. PubMed ID: 7741070
    [Abstract] [Full Text] [Related]

  • 15. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
    Colón-Otero G, Marschke R, Camoriano JK, Sorensen JM, Sloan JA, Richardson RL.
    Cancer J Sci Am; 1997 Mar 15; 3(5):297-302. PubMed ID: 9327154
    [Abstract] [Full Text] [Related]

  • 16. [Clinical study of modified M-VAC therapy with one 21-day cycle for advanced urothelial cancer].
    Nakanishi S, Matsuzaki M, Morikawa H, Nakano M, Komatsu H.
    Hinyokika Kiyo; 2004 Oct 15; 50(10):667-71. PubMed ID: 15575216
    [Abstract] [Full Text] [Related]

  • 17. Cisplatin, ifosfamide, methotrexate and vinblastine combination chemotherapy for metastatic urothelial cancer.
    Kyriakakis Z, Dimopoulos MA, Kostakopoulos A, Karayiannis A, Sofras F, Zervas A, Giannopoulos A, Dimopoulos C.
    J Urol; 1997 Aug 15; 158(2):408-11. PubMed ID: 9224313
    [Abstract] [Full Text] [Related]

  • 18. [Therapeutic experiences of cis-diamminedichloroplatinum, adriamycin and 5-fluorouracil combination chemotherapy in advanced urothelial cancer, with special reference to adjuvant chemotherapy in invasive urothelial cancer].
    Ogawa O, Yoshimura N, Taniguchi T, Nishimura K, Nakagawa T.
    Hinyokika Kiyo; 1986 Jun 15; 32(6):795-802. PubMed ID: 3766338
    [Abstract] [Full Text] [Related]

  • 19. Methotrexate-paclitaxel-epirubicin-carboplatin (M-TEC) combination chemotherapy in patients with advanced bladder cancer: an open label phase II study.
    Tsavaris N, Kosmas C, Skopelitis H, Dimitrakopoulos A, Kopterides P, Bougas D, Stravodimos K, Mitropoulos D, Alamanis C, Giannopoulos A.
    J Chemother; 2005 Aug 15; 17(4):441-8. PubMed ID: 16167525
    [Abstract] [Full Text] [Related]

  • 20. [Polychemotherapy using the M-VEC protocol (methotrexate, vinblastine, epirubicin, cisplatin) in advanced urinary bladder cancer--effectiveness and toxicity].
    Rassweiler J, Rüther U, Bäuerle K, Bub P, Jipp P, Eisenberger F.
    Urologe A; 1989 Jan 15; 28(1):25-30. PubMed ID: 2922897
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.